Literature DB >> 21567836

A research-inspired laboratory sequence investigating acquired drug resistance.

Elizabeth Vogel Taylor1, Jennifer A Fortune, Catherine L Drennan.   

Abstract

Here, we present a six-session laboratory exercise designed to introduce students to standard biochemical techniques in the context of investigating a high impact research topic, acquired resistance to the cancer drug Gleevec. Students express a Gleevec-resistant mutant of the Abelson tyrosine kinase domain, the active domain of an oncogenic protein implicated in chronic myelogenous leukemia, and investigate the kinase activity of wild type and mutant enzyme in the presence of two cancer drugs. Techniques covered include protein expression, purification, and gel analysis, kinase activity assays, and protein structure viewing. The exercises provide students with a hands-on understanding of the impact of biochemistry on human health, and demonstrate their potential as the next generation of investigators.
Copyright © 2010 The International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Year:  2010        PMID: 21567836      PMCID: PMC5996378          DOI: 10.1002/bmb.20384

Source DB:  PubMed          Journal:  Biochem Mol Biol Educ        ISSN: 1470-8175            Impact factor:   1.160


  10 in total

1.  New hope for cancer.

Authors:  M D Lemonick; A Park
Journal:  Time       Date:  2001-05-28

2.  Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.

Authors:  Ian J Griswold; Mary MacPartlin; Thomas Bumm; Valerie L Goss; Thomas O'Hare; Kimberly A Lee; Amie S Corbin; Eric P Stoffregen; Caitlyn Smith; Kara Johnson; Erika M Moseson; Lisa J Wood; Roberto D Polakiewicz; Brian J Druker; Michael W Deininger
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

3.  A project-based biochemistry laboratory promoting the understanding and uses of fluorescence spectroscopy in the study of biomolecular structures and interactions.

Authors:  Nicholas Briese; Henry V Jakubowski
Journal:  Biochem Mol Biol Educ       Date:  2007-07-03       Impact factor: 1.160

4.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.

Authors:  T Schindler; W Bornmann; P Pellicena; W T Miller; B Clarkson; J Kuriyan
Journal:  Science       Date:  2000-09-15       Impact factor: 47.728

5.  An integrated protein chemistry laboratory: Chlorophyll and chlorophyllase.

Authors:  Kiani A J Arkus; Joseph M Jez
Journal:  Biochem Mol Biol Educ       Date:  2008-03       Impact factor: 1.160

6.  The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants.

Authors:  John S Tokarski; John A Newitt; Chieh Ying J Chang; Janet D Cheng; Michael Wittekind; Susan E Kiefer; Kevin Kish; Francis Y F Lee; Robert Borzillerri; Louis J Lombardo; Dianlin Xie; Yaqun Zhang; Herbert E Klei
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

7.  High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

Authors:  Markus A Seeliger; Matthew Young; M Nidanie Henderson; Patricia Pellicena; David S King; Arnold M Falick; John Kuriyan
Journal:  Protein Sci       Date:  2005-10-31       Impact factor: 6.725

Review 8.  Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia.

Authors:  Ellen Weisberg; Paul W Manley; Sandra W Cowan-Jacob; Andreas Hochhaus; James D Griffin
Journal:  Nat Rev Cancer       Date:  2007-05       Impact factor: 60.716

Review 9.  Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia.

Authors:  Jane F Apperley
Journal:  Lancet Oncol       Date:  2007-11       Impact factor: 41.316

10.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).

Authors:  Bhushan Nagar; William G Bornmann; Patricia Pellicena; Thomas Schindler; Darren R Veach; W Todd Miller; Bayard Clarkson; John Kuriyan
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

  10 in total
  1 in total

1.  A semester-long project-oriented biochemistry laboratory based on Helicobacter pylori urease.

Authors:  Kate R Farnham; Danielle H Dube
Journal:  Biochem Mol Biol Educ       Date:  2015-07-14       Impact factor: 1.160

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.